Published in

Wiley, Cochrane Library, 2016

DOI: 10.1002/14651858.cd012395

Links

Tools

Export citation

Search in Google Scholar

Pharmacological treatment for familial amyloid neuropathy

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess and compare the efficacy, acceptability, and tolerability of pharmacologic disease-modifying agents for familial amyloid neuropathy (FAP).